Pre-market
Loading markets…

Advertisement

Stocks

What's Going On With VentriPoint Diagnostics Ltd Stock Thursday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:VPT.V

Get VPT alerts:

Photos provided by Pexels

VentriPoint Diagnostics Ltd (VPT.V) has seen a slight uptick in its stock performance this week as the company continues to navigate its financing and commercialization efforts.

This week, VentriPoint Diagnostics Ltd (TSXV: VPT) experienced a modest gain of 5.56%, closing at C$0.10. This movement comes amid ongoing efforts to enhance its AI-enabled echocardiography technology, although there have been no recent major announcements affecting the stock directly.

Advertisement

VentriPoint Diagnostics Ltd

VPT.V

Full stock page →

VPT.V

VentriPoint Diagnostics Ltd

Source:WealthAwesomeWealthAwesome
$0.01 (-13.64%)
120 day period
$0.09$0.13$0.17Mar 11Jun 10Sep 9

Market cap

$18.32M

52W high

$0.19

52W low

$0.08

1W change

+5.56%

Beta

0.04

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on VPT's historical volatility

HistoricalForecast68%95%
C$0.04C$0.07C$0.10C$0.12C$0.15C$0.18TodayApr 27Jul 2Sep 9Oct 22Dec 5Jan 17

30-Day Vol

51.4%

Annualized

90-Day Vol

94.5%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.08

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.09C$0.07C$0.11
60 trading daysC$0.08C$0.07C$0.11
90 trading daysC$0.08C$0.06C$0.11

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should keep an eye on VentriPoint's ongoing financing activities and partnerships, as these could impact the company’s growth trajectory and stock performance moving forward.

VPT.V's 52-week range shows volatility: C$0.08 – C$0.19.

Currently trading at C$0.10, VentriPoint is at approximately 18% of its 52-week range, suggesting potential room for upward movement if commercial efforts succeed.

Bull case

The company's recent private placements and strategic partnerships show a strong commitment to commercialization. This could lead to increased revenue and attract more investor interest.

Bear case

However, with a significant drop in year-to-date performance and a negative return on equity, investors may remain cautious about potential risks tied to ongoing financing and operational challenges.

Weekly Price Action

This week, VentriPoint Diagnostics Ltd saw its stock price close at C$0.10, representing a flat performance of 0.00% for the day but a notable increase of 5.56% over the past week. The stock has been relatively stable, reflecting ongoing interest as the company works on its strategic initiatives.

Recent Company News

Advertisement

While there were no major announcements this week, recent headlines indicate that VentriPoint has been actively engaging in financing activities. Notably, the company closed the first tranche of a $350,000 non-brokered private placement aimed at accelerating the commercialization of its VMS+™ technology. This is part of a broader strategy to enhance its market presence and operational capabilities.

Technical Picture

From a technical perspective, VPT.V is currently trading below both its 50-day moving average of C$0.11 and its 200-day moving average of C$0.12, indicating a bearish trend in the short to medium term. The stock has a beta of 0.04, suggesting low volatility compared to the market. The current trading volume of 216,700 shares is significantly higher than the 20-day average volume of 120,316 shares, indicating increased investor interest.

Insider Activity

No recent insider activity has been reported for VentriPoint Diagnostics Ltd, which may suggest stability in management and ownership during this phase of growth.

Price Action Summary

As of the last close, VentriPoint Diagnostics Ltd (VPT.V) stood at C$0.10, with a weekly gain of 5.56%. Investors will be monitoring the company's efforts in commercialization and financing closely as these elements could influence future stock performance.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 10, 2026
Last Updated: September 10, 2026
PARTNER SPOTLIGHT

Blue Cross Life® Term Life Insurance

Affordable term life coverage in Canada — get a free quote in seconds, no credit card required.

  • Coverage from $100,000 to $5 million, terms of 10–30 years
  • 10% off first-year premiums when couples apply together
  • Fully digital application — many qualify without a medical exam

Sponsored links

Advertisement